Assertio Therapeutics Inc (ASRT) — Cash Flow-to-Debt Ratio
Assertio Therapeutics Inc (ASRT) has a Cash Flow-to-Debt Ratio of 0.06x as of March 2026, meaning its operating cash flow of $8.56 Million could theoretically repay 0% of its total liabilities ($135.67 Million) in one year. See how financially flexible is Assertio Therapeutics Inc to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Assertio Therapeutics Inc Cash Flow-to-Debt Ratio (1996–2025)
Historical debt coverage capacity for Assertio Therapeutics Inc across 30 annual periods. For the full cash flow conversion analysis, see Assertio Therapeutics Inc cash conversion from operations.
Annual Cash Flow-to-Debt Ratio for Assertio Therapeutics Inc (1996–2025)
Year-by-year debt coverage analysis for Assertio Therapeutics Inc. Check how high is Assertio Therapeutics Inc's earnings quality to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.16x | $-28.18 Million | $173.02 Million | ▼ -200.9% |
| 2024 | 0.16x | $26.41 Million | $163.65 Million | ▼ -51.7% |
| 2023 | 0.33x | $49.60 Million | $148.42 Million | ▼ -20.0% |
| 2022 | 0.42x | $78.60 Million | $188.19 Million | ▲ +1594.9% |
| 2021 | 0.02x | $5.52 Million | $224.13 Million | ▲ +109.3% |
| 2020 | -0.26x | $-65.57 Million | $247.76 Million | ▼ -237.3% |
| 2019 | 0.19x | $90.47 Million | $469.21 Million | ▲ +89.5% |
| 2018 | 0.10x | $72.50 Million | $712.53 Million | ▲ +42.2% |
| 2017 | 0.07x | $62.17 Million | $869.11 Million | ▲ +6.4% |
| 2016 | 0.07x | $65.50 Million | $974.55 Million | ▼ -51.0% |
| 2015 | 0.14x | $143.89 Million | $1.05 Billion | ▲ +185.1% |
| 2014 | -0.16x | $-55.92 Million | $346.62 Million | ▼ -714.0% |
| 2013 | 0.03x | $9.75 Million | $371.24 Million | ▲ +104.9% |
| 2012 | -0.54x | $-30.98 Million | $57.72 Million | ▼ -154.4% |
| 2011 | 0.99x | $57.65 Million | $58.45 Million | ▲ +2747.9% |
| 2010 | -0.04x | $-2.38 Million | $63.92 Million | ▼ -253.7% |
| 2009 | 0.02x | $1.84 Million | $75.86 Million | ▼ -55.2% |
| 2008 | 0.05x | $3.35 Million | $61.93 Million | ▼ -87.0% |
| 2007 | 0.42x | $14.66 Million | $35.12 Million | ▲ +220.4% |
| 2006 | -0.35x | $-27.70 Million | $79.91 Million | ▼ -171.7% |
| 2005 | 0.48x | $28.82 Million | $59.62 Million | ▲ +130.0% |
| 2004 | -1.61x | $-23.27 Million | $14.47 Million | ▲ +36.4% |
| 2003 | -2.53x | $-33.15 Million | $13.12 Million | ▼ -1585.4% |
| 2002 | -0.15x | $-4.44 Million | $29.59 Million | ▲ +87.6% |
| 2001 | -1.21x | $-12.40 Million | $10.22 Million | ▲ +24.4% |
| 2000 | -1.60x | $-6.65 Million | $4.15 Million | ▼ -437.5% |
| 1999 | -0.30x | $-3.94 Million | $13.22 Million | ▲ +86.9% |
| 1998 | -2.27x | $-2.50 Million | $1.10 Million | ▼ -3.3% |
| 1997 | -2.20x | $-1.10 Million | $500.00K | ▼ -285.0% |
| 1996 | -0.57x | $-400.00K | $700.00K | — |